Together, these findings indicated that YTHDF2 plays an oncogenic role in gliomas and its expression is positively associated with increased malignant phenotype of gliomas, and may influence the cell cycle of glioma cells through regulation of RNA metabolism. This evidence concerns the gene YTHDF2 and central nervous system cancer.